dr. M.C.J.M. (Miriam) Sturkenboom Associate Professor

Department of Epidemiology
Julius Center Research Program Cardiovascular Epidemiology

Contact

m.c.j.sturkenboom@umcutrecht.nl

Biography
Research Output

Biography

Miriam Sturkenboom is pharmacoepidemiologist. She is professor in Observational Data Analysis and worked until 2017 at the department of Medical Informatics of the Erasmus University Medical Center in the Netherlands. Mid 2017 she transferred to the Global Health Group at the Julius Center at University Medical Center Utrecht in the Netherlands. She has a PhD from the Faculty of Mathematics and Physics in Groningen (cum laude), a pharmacy degree from the same University and a Master in Epidemiology from the Harvard School of Public Health. She is past president of the International Society for Pharmacoepidemiology. She serves as expert to EMA, FDA, WHO and many other organizations

Her research interests focus on transforming real world data into real world evidence on drug use, effectiveness and safety in vulnerable populations (children, pregnancy and elderly). Her research focuses on the creation of international ecosystems that allow for big data mining, pooling and analysis to learn about the use and effects of drugs after marketing. These infrastructures have been tested and used as prototypes in many distributed networks in projects funded by the European Commission, the Innovative Medicines Initiative, the European Medicines Agency, ECDC, and also privately funded projects that she coordinate(d/s). She was coordinator of the IMI funded ADVANCE public private collaboration, aiming to establish a tested system for the monitoring of benefits and risks of vaccines. She is coordinator of the IMI-funded ConcepTION project, building an ecosystem to assess drugs safety in pregnancy and lactation. She is member of the WHO Global Advisory Committee for Vaccine Saftey. In terms of quantitative research outputs: she supervises/d more than 50 PhD students, has more than 400 peer reviewed papers in the area of pharmacovigilance, pharmacoepidemiology and medical informatics and an h-index of 74.

Research Output

Asthma treatment in real life

Baan Esme J., Karimi Leila, Heeremans Astrid, Brusselle Guy G., Sturkenboom Miriam, Janssens Hettie M., Lahousse Lies, Verhamme Katia M. Aug 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 337-337

Advance system testing: Benefit-risk analysis of a marketed vaccine using cohort modelling and MCDA swing weighting

Bollaerts Kaatje, Ledent Eduoard, De Smedt Tom, Weibel Daniel, Emborg Hanne-Dorthe, Berensci Klara, Correa Ana, Danieli Giorgia, Duarte-Salles Talita, Huerta Consuelo, Martin Elisa, Picelli Gino, Tram Lara, Titievsky Lina, Titievsky Lina, Sturkenboom Miriam, Bauchau Vincent Aug 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 12-13

Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi- database study in 5 EU countries by the EU-ADR Alliance

Ali M. Sanni, Berencsi Klara, Marnier Karine, Deltour Nicolas, Pedersen Lars, Rijnbeek Peter, Lapi Francesco, Simonetti Monica, Sturkenboom Miriam, Van der Lei Johan, Van der Lei Johan, Prieto-Alhambra Daniel Aug 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 186-187

The effect of inhaled corticosteroids on hair cortisol

Baan Esme J., Van Den Akker Erica L. T., De Rijke Yolanda B., De Jongste Johan C., Sturkenboom Miriam, Verhamme Katia M., Engelkes Marjolein, Janssens Hettie M. Aug 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 287-287

Challenges and potential of vaccine post-licensure benefit-risk assessments in resource limited countries

Weibel Daniel, Zuber Patrick, Khromava Alena, Oduro Abraham, Stergachis Andy, Stark James, Seifert Harry, Sturkenboom Miriam, Black Steve, Sutherland Andrea Aug 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 361-362

PRO-ARRHYTHMIC POTENTIAL OF ORAL ANTIHISTAMINES (H1): COMBINING ADVERSE EVENT REPORTS DATA WITH DRUG UTILIZATION DATA ACROSS EUROPE

Poluzzi E., Raschi E., Godman B., Koci A., Moretti U., Kalaba M., Wettermark B., Sturkenboom M., De Ponti F. Jul 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. O10-O11

Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination

Perez-Vilar Silvia, Weibel Daniel, Sturkenboom Miriam, Black Steven, Maure Christine, Castro Jose Luis, Bravo-Alcantara Pamela, Dodd Caitlin N., Romio Silvana A., de Ridder Maria, Nakato Swabra, Molina-Leon Helvert Felipe, Elango Varalakshmi, Zuber Patrick L. F. 8 Jan 2018 In: Vaccine. 36, p. 347-354 8 p.

Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network

Bravo-Alcantara Pamela, Perez-Vilar Silvia, Molina-Leon Helvert Felipe, Sturkenboom Miriam, Black Steven, Zuber Patrick L. F., Maure Christine, Castro Jose Luis 8 Jan 2018 In: Vaccine. 36, p. 363-370 8 p.

Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct

Sturkenboom Miriam 4 Jan 2018 In: Vaccine. 36, p. 194-195 2 p.

Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project

Poluzzi Elisabetta, Diemberger I., de Ridder M., Koci A., Clo M., Oteri A., Pecchioli S., Bezemer I.D., Schink T., Pilgaard Ulrichsen S., Boriani G., Sturkenboom M. C.J., De Ponti F., Trifirò G. 1 Nov 2017 In: European Journal of Clinical Pharmacology. 73, p. 1499-1510 12 p.

All Research Output (40)

Contact

Biography

Research Output

Deze website maakt gebruik van cookies